Literature DB >> 9425230

Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.

L T Braiterman1, S Zheng, P A Watkins, M T Geraghty, G Johnson, M C McGuinness, A B Moser, K D Smith.   

Abstract

X-Linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disorder characterized by reduced peroxisomal very long chain fatty acid (VLCFA) beta-oxidation. The X - ALD gene product (ALDP) is a peroxisomal transmembrane protein with an ATP binding cassette (ABC). ALDP and three other ABC proteins (PMP70, ALDR, P70R) localize to the peroxisomal membrane. The function of this family of peroxisomal membrane proteins is unknown. We used complementation studies to begin analysis of their role in VLCFA beta-oxidation and on the peroxisomal membrane. Expression of either ALDP or PMP70 restores VLCFA beta-oxidation in X-ALD fibroblasts, indicating overlapping functions. Their expression also restores peroxisome biogenesis in cells that are deficient in the peroxisomal membrane protein Pex2p. Thus it is likely that complex protein interactions are involved in the function and biogenesis of peroxisomal membranes that may contribute to disease heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9425230     DOI: 10.1093/hmg/7.2.239

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

Review 1.  Disorders related to peroxisomal membranes.

Authors:  J Gärtner
Journal:  J Inherit Metab Dis       Date:  2000-05       Impact factor: 4.982

2.  ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.

Authors:  Mauhamad Baarine; Craig Beeson; Avtar Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

Review 3.  On the front of X-linked adrenoleukodystrophy.

Authors:  P Aubourg
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 4.  X-linked adrenoleukodystrophy: genes, mutations, and phenotypes.

Authors:  K D Smith; S Kemp; L T Braiterman; J F Lu; H M Wei; M Geraghty; G Stetten; J S Bergin; J Pevsner; P A Watkins
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 5.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

6.  Assembly properties of lamprey neurofilament subunits and their expression after spinal cord transection.

Authors:  Guixin Zhang; Liqing Jin; Michael E Selzer
Journal:  J Comp Neurol       Date:  2011-12-15       Impact factor: 3.215

7.  Identification of a new fatty acid synthesis-transport machinery at the peroxisomal membrane.

Authors:  Merle Hillebrand; Søren W Gersting; Amelie S Lotz-Havla; Annika Schäfer; Hendrik Rosewich; Oliver Valerius; Ania C Muntau; Jutta Gärtner
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

Review 8.  The peroxisomal ABC transporter family.

Authors:  Ronald J A Wanders; Wouter F Visser; Carlo W T van Roermund; Stephan Kemp; Hans R Waterham
Journal:  Pflugers Arch       Date:  2006-10-13       Impact factor: 3.657

9.  Probing substrate-induced conformational alterations in adrenoleukodystrophy protein by proteolysis.

Authors:  Carla P Guimarães; Clara Sá-Miranda; Jorge E Azevedo
Journal:  J Hum Genet       Date:  2005-01-29       Impact factor: 3.172

10.  Identification of six loci in which mutations partially restore peroxisome biogenesis and/or alleviate the metabolic defect of pex2 mutants in podospora.

Authors:  Gwenaël Ruprich-Robert; Véronique Berteaux-Lecellier; Denise Zickler; Arlette Panvier-Adoutte; Marguerite Picard
Journal:  Genetics       Date:  2002-07       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.